| 35.08 Data as of May 24 |  -0.10 / -0.28%Today’s Change | 28.62 Today|||52-Week Range 37.78 | +12.29% Year-to-Date |
| Interesting HSP Put And Call For July May 20 / TheStreet.com |
| Previous close | 35.18 |
| Today’s open | 34.97 |
| Day’s range | 34.72 - 35.32 |
| Volume | 518,587 |
| Average volume (3 months) | 1,494,574 |
| Market cap | $5.8B |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.02% |
| Earnings growth (next 5 years) | +4.74% |
| Revenue growth (last year) | +0.86% |
| P/E ratio | NM |
| Price/Sales | 1.26 |
| Price/Book | 1.91 |
| Today’s change | Today’s % change | |
|---|---|---|
| PCYCPharmacyclics Inc | +0.01 | +0.01% |
| ELNElan Corporation PLC | +0.11 | +0.89% |
| RDYDr.Reddy's Laborator... | +0.20 | +0.54% |
| WCRXWarner Chilcott Plc | -0.04 | -0.20% |
| Next reporting date | July 31, 2013 |
| EPS forecast (this quarter) | $0.51 |
| Annual revenue (last year) | $4.1B |
| Annual profit (last year) | $44.2M |
| Net profit margin | 1.08% |
Sector Health Technology |
Industry Medical Specialties |
Chief Executive Officer & Director F. Michael Ball, MBA |
Senior Vice President- Operations Matthew R. Stober |
Corporate headquarters Lake Forest, Illinois |
.
